Duch Ditto raises €7.6M for patient-side AI summaries of medical appointments
May 12, 2026
Ditto, an Amsterdam-based health-tech startup, has secured €7.6 million in funding, as announced on Monday. The round was led by Heal Capital with the participation of Rubio Impact Ventures. Prior investor Chris Oomen, chair of Optiverder, also contributed.
The funding will be allocated for expansion into Germany, the UK, and Spain this year, as well as continued development of the company’s consumer product.
Ditto was founded by CEO Tobias Lensing, along with co-founders Bart Voorn and Merlijn van Breugel, after Lensing witnessed a friend with stage-4 bile-duct cancer struggling to recall the details of their medical appointment.
The company offers a mobile app that, with patient consent, records medical consultations and generates a clear, concise summary. This summary can be reviewed, shared with family, and used to prepare for follow-up appointments.
Patient-Centric AI in Healthcare
Ditto’s approach diverges from the current trend in AI healthcare, which primarily focuses on tools for clinicians. Instead, they argue that serving patients directly presents a lower-cost, higher-impact opportunity.
The app launched in the Netherlands with support from the national Patient Federation, aiming for 10,000 downloads within six months. They achieved this milestone in under two weeks and now boast over 100,000 users, receiving 4.7-star ratings on both the App Store and Google Play.
Patient Outcomes and Leveraging AI
Lensing emphasizes the importance of patient understanding:
"Almost every AI company in healthcare today is building for doctors. All useful. But nobody is building for the person on the other side of the desk: the one who actually has to live with the diagnosis, remember the instructions, and explain it to their family that evening."
Ditto positions itself as a leverage point for improved patient outcomes:
"The strongest medicine isn’t a drug. It’s a patient who knows what’s going on."
The platform is free for patients, funded through partnerships with insurers, patient organizations, and healthcare institutions, with the goal of reducing follow-up calls, repeat explanations, and missed appointments.
Heal Capital, one of Europe’s most active health-tech investors, and Rubio Impact Ventures, focusing on underserved populations, participated in this round.